Ticker Details
Ventyx Biosciences, Inc.
IPO Date:	October 21, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1B
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.47 | 3.80%
Avg Daily Range (30 D):	$0.01 | 0.06%
Avg Daily Range (90 D):	$0.21 | 2.28%

Institutional Daily Volume
Avg Daily Volume:	1.29M
Avg Daily Volume (30 D):	1.21M
Avg Daily Volume (90 D):	2.36M

Trade Size
Avg Trade Size (Sh.):	134
Avg Trade Size (Sh.) (30 D):	544
Avg Trade Size (Sh.) (90 D):	213

Institutional Trades
Total Institutional Trades:	1,413
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$.9M
Avg Institutional Trade (90 D):	$2.25M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.02M
Avg Closing Trade (30 D):	$.94M
Avg Closing Trade (90 D):	$1.26M
Avg Closing Volume:	132.51K

News

Feb 4, 2026 @ 6:16 PM SHAREHOLDER ALERT: The M&A Class Action Firm Is In... Source: Prnewswire

Feb 3, 2026 @ 8:00 PM Halper Sadeh LLC is Investigating STEL, CLBK, NFBK... Source: Halper Sadeh Llc

Jan 23, 2026 @ 6:40 PM SHAREHOLDER ALERT: The M&A Class Action Firm Conti... Source: Prnewswire

Jan 21, 2026 @ 7:42 PM Halper Sadeh LLC Encourages VTYX and SNCY Sharehol... Source: Halper Sadeh Llc

Jan 21, 2026 @ 4:00 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.49	$-.32	$-.38
Diluted EPS	$-1.49	$-.32	$-.38
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-106.61M	$-22.83M	$-26.99M
Operating Income / Loss	$-116.72M	$-24.87M	$-29.33M
Cost of Revenue
Net Cash Flow	$-29.85M	$-.25M	$4.68M
PE Ratio